Metraipolis › archive › dc_2f02113bad4d

Next-generation cancer vaccines: targeting cryptic and non-canonical antigens for precision immunotherapy — Europe PMC PMID:41018485

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41018485
DOI
10.37349/etat.2025.1002338
License (as archived)
solo-consultazione
Archived
2026-11-09T18:17:26.325Z
SHA-256 of the archived text
dc48a3cde770458a101248e2d9b4fd1850cacd3795bdbffcd73b94e5c3c9dec6
Stable URL of this page
https://metraipolis.com/documento/dc_2f02113bad4d

How to cite

Next-generation cancer vaccines: targeting cryptic and non-canonical antigens for precision immunotherapy — Europe PMC PMID:41018485 — Europe PMC (en), https://europepmc.org/article/MED/41018485 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f02113bad4d (Metraipolis archive dc_2f02113bad4d, sha256 dc48a3cde770458a101248e2d9b4fd1850cacd3795bdbffcd73b94e5c3c9dec6)
BibTeX
@misc{dc2f02113bad4d,
  title = {Next-generation cancer vaccines: targeting cryptic and non-canonical antigens for precision immunotherapy — Europe PMC PMID:41018485},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41018485},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f02113bad4d; sha256 dc48a3cde770458a101248e2d9b4fd1850cacd3795bdbffcd73b94e5c3c9dec6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41018485. Agents can read the archived copy with the MCP tool read_document.